Clinical Trials
| Novartis CVHB937A12201 | |
| Therapeutic Area Name | Neurosciences |
| Condition or Disease | Early Alzheimer's Disease |
| Title | A randomized, placebo-controlled, parallel group, 72-week study to evaluate the efficacy and safety of VHB937 in participants with early Alzheimer’s Disease followed by an Extension |
| Study ID | Novartis CVHB937A12201 |
| Principal Investigator First Name | Concetta |
| Principal Investigator Last Name | Forchetti |
| Clinicaltrials.gov | NCT07094516 |